Supernus Pharmaceuticals Inc logo

Supernus Pharmaceuticals Inc

NEW
LTS:0LB2 (USA)  
$ 47.23 (0%) Jul 3
At Loss
P/B:
2.59
Market Cap:
$ 2.79B
Enterprise V:
$ 2.45B
Volume:
7.00
Avg Vol (2M):
55.00
Trade In:
Volume:
7.00
At Loss
Avg Vol (2M):
55.00

Supernus Pharmaceuticals Inc Valuation Measures